Cue Health Stock

Cue Health ROCE

The Return on Capital Employed (ROCE) of Cue Health (HLTHQ) as of Aug 7, 2026 is -118.57 %. In the previous year, Return on Capital Employed (ROCE) was -35.33 % — a change of 235.56% (lower).

ROCE

-118.57 %

YoY

235.56%

Last updated:

In 2026, Cue Health's return on capital employed (ROCE) was -118.57 %, a 235.56% increase from the -35.33 % ROCE in the previous year.

Access this data via the Eulerpool API

Cue Health Stock analysis

What does Cue Health do? Cue Health Inc. is a San Diego-based company specialized in the development and distribution of smart, mobile diagnostic devices. The company was founded in 2010 by Ayub Khattak and Dan Sullivan and has since expanded into various sectors. Cue Health's main business is the development of diagnostic devices that allow end-users to quickly and easily perform diagnostic tests. With a handheld device and proprietary software, customers can perform a wide range of tests in many areas, including tests for flu, colds, inflammatory diseases, sexually transmitted diseases, and COVID-19. Cue Health's business model is based on the idea of providing user-friendliness and portability in the field of diagnostics. With the technology, patients can independently perform diagnostic tests without having to visit a doctor. This not only saves time but also reduces costs for the customer. Since its founding, Cue Health has expanded into several sectors. In addition to the handheld diagnostic device, the company also offers solutions for the healthcare services sector. Through partnerships with biotech companies and medical institutions, the company assists in the development and marketing of diagnostic tests. An important part of Cue Health's history is the development of COVID-19 tests. The company quickly responded to develop a solution for COVID-19 tests that are both safe and easier to use. The Cue COVID-19 Test Kit complies with the requirements of the US Food and Drug Administration and is used in the USA. The test only requires a simple nasal swab, which is then inserted into the handheld device. Within minutes, the user receives the test result. Cue Health intends to continue expanding its technology to offer users a wider range of diagnostic test solutions. The previous tests have shown that the company is capable of delivering innovative solutions to the diagnostics market. The ability to receive fast, accurate, and affordable diagnostic solutions is invaluable for many people, especially those in hard-to-reach locations and without direct access to medical professionals. Overall, Cue Health is a highly innovative company specializing in excellent diagnostic technology and products for the healthcare industry. The products and services of Cue Health have the potential to revolutionize healthcare for all by making diagnostic tests safer, faster, and more convenient. Cue Health is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Cue Health's Return on Capital Employed (ROCE)

Cue Health's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Cue Health's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Cue Health's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Cue Health’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Cue Health stock

Return on Capital Employed (ROCE) of Cue Health is -118.57 % in 2026.

Return on Capital Employed (ROCE) of Cue Health changed from -35.33 % to -118.57 %, representing a 235.56% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Cue Health since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Cue Health with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

Profitability — Cue Health

All Key Metrics — Cue Health